Education
About Us
Working with TipRanks
Follow Us
Amy L. Burroughs Insider Profile
4 Followers
Amy L. Burroughs, Director at Diamedica Therapeutics, holds 73.29K shares in Diamedica Therapeutics (Ticker: DMAC), holds ― shares in Tenaya Therapeutics (Ticker: TNYA), holds 19.61K shares in Terns Pharmaceuticals (Ticker: TERN).
Amy L. Burroughs has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Amy L. Burroughs holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 17, 2021 - Aug 17, 2022
Return:-50.40%
The most profitable trade made by Amy L. Burroughs
Amy L. Burroughs's Trading History
Diamedica Therapeutics
Jan 03, 2023
Director
Uninformative Buy
26.25K
$422.87K
Tenaya Therapeutics
―
Director
―
―
Terns Pharmaceuticals
Feb 03, 2025
CEO, Director
Uninformative Buy
2.61K
$68.44K
List of latest transactions for each holding click on a transaction to see Amy L. Burroughs's performance on stock
You May Also Like
Amy L. Burroughs insider profile FAQ
What is the percentage of profitable transactions made by Amy L. Burroughs?
The percentage of profitable transactions made by Amy L. Burroughs is ―.
What is the average return per transaction made by Amy L. Burroughs?
The average return per transaction made by Amy L. Burroughs is ―.
What stocks does Amy L. Burroughs hold?
Amy L. Burroughs holds: DMAC, TNYA, TERN stocks.
What was Amy L. Burroughs’s latest transaction?
Amy L. Burroughs latest transaction was an Uninformative Buy of $26.25K.
What was Amy L. Burroughs's most profitable transaction?
Amy L. Burroughs’s most profitable transaction was an Informative Buy of DMAC stock on August 17, 2021. The return on the trade was -50.40%.
What is Amy L. Burroughs's role in Diamedica Therapeutics?
Amy L. Burroughs's role in Diamedica Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.